New incident report
Incident Report Number: 2010-3764
Registrant Reference Number: PROSAR Case # 1-22864752
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: UNITED STATES
Prov / State: NORTH CAROLINA
PMRA Registration No. PMRA Submission No. EPA Registration No. 2596-139
Product Name: UltraGuard Plus Flea/Tick Collar for Cats/Kittens Safety Release
Other (specify)
Treated collarYes
Unknown
Site: Animal / Usage sur un animal domestique
Unknown
Other
Cat / Chat
Domestic Longhair
1
Male
0.67
5
lbs
Skin
Unknown / Inconnu
Unknown / Inconnu
System
Persisted until death
No
No
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
1-22864752: The reporter called on 6/3/10 to report the death of her parent¿s kitten (8 month old, male DLH) after the kitten was exposed to a flea and tick collar containing the active ingredients Methoprene and Tetrachlorvinphos. According to the reporter, a collar had been applied to her parent's 2 cats (a cat and a kitten) on 5/31/10. The kitten became lethargic and developed vomiting within 24 hours of product application. The owners removed the collar and contacted their veterinarian, who instructed them to bathe the kitten and keep him hydrated. The kitten's symptoms continued throughout the day, so the owners repeated their call to the veterinarian. They were told that the symptoms should pass; however, the kitten¿s symptoms continued to persist and the owners planned to bring him in to the veterinarian on 6/3. During the evening of 6/2/10, the kitten had a seizure, experienced difficulty breathing, and went into respiratory arrest. The kitten died and was buried. The reporter speculated that in addition to the dermal exposure from the collar itself, the kitten may have ingested the collar¿s powder off his coat during grooming. During the 6/3 call, the safety profile of the product was discussed, including the fact that the symptoms as described would not be expected with labeled use.
Death